home / stock / aspcf / aspcf quote
Last: | $0.21988 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.21988 |
High: | $0 |
Low: | $0 |
Volume: | 500 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.21988 | $0 | $0.21988 | $0 | $0 | 500 | 01-24-2023 |
$0.21988 | $0.21988 | $0.21988 | $0.21988 | $0.21988 | 2,000 | 01-12-2023 |
$0.3659 | $0 | $0.3659 | $0 | $0 | 50 | 01-10-2023 |
$0.3659 | $0.3659 | $0.3659 | $0.3659 | $0.3659 | 1,000 | 01-06-2023 |
$0.5579 | $0.5579 | $0.5579 | $0.5579 | $0.5579 | 1,023 | 12-28-2022 |
$0.85 | $0 | $0.85 | $0 | $0 | 100 | 12-23-2022 |
$0.85 | $0 | $0.85 | $0 | $0 | 42 | 12-20-2022 |
$0.85 | $0 | $0.85 | $0 | $0 | 5 | 12-15-2022 |
$0.85 | $0 | $0.85 | $0 | $0 | 50 | 12-07-2022 |
$0.85 | $0.85 | $0.85 | $0.85 | $0.85 | 100 | 11-29-2022 |
$0.9883 | $0 | $0.9883 | $0 | $0 | 91 | 11-22-2022 |
$0.9883 | $0.9883 | $0.9883 | $0.9883 | $0.9883 | 192 | 11-15-2022 |
$1.08 | $0 | $1.08 | $0 | $0 | 8 | 11-09-2022 |
$1.08 | $0 | $1.08 | $0 | $0 | 100 | 11-07-2022 |
$1.08 | $1.08 | $1.08 | $1.08 | $1.08 | 350 | 10-26-2022 |
$1.23 | $1.2616 | $1.23 | $1.2616 | $1.23 | 278 | 10-19-2022 |
$1.3235 | $0 | $1.3235 | $0 | $0 | 76 | 10-05-2022 |
$1.3235 | $1.32 | $1.3235 | $1.3335 | $1.32 | 2,275 | 09-30-2022 |
$1.85 | $1.85 | $1.85 | $1.85 | $1.85 | 102 | 09-22-2022 |
$1.41 | $1.41 | $1.41 | $1.41 | $1.41 | 500 | 09-19-2022 |
News, Short Squeeze, Breakout and More Instantly...
Acerus Pharmaceuticals Corp Company Name:
ASPCF Stock Symbol:
OTCMKTS Market:
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- As announced on January 26, 2023, Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) and its subsidiaries were granted creditor protection pursuant to an order (the “ Initial Order ”) g...
TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively, “ Acerus ”) were granted protection pursuant to an order (the “ Initial Order ”) issued under the Companies ...
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “ Company ” or “ Acerus ”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus Biopharma Inc., Acerus Labs Inc. and Acerus Pharmaceuticals USA,...